317 related articles for article (PubMed ID: 7048633)
1. Liver membrane autoantibodies: methods for their detection and clinical significance.
Nagai S; Manns M; Meyer zum Büschenfelde KH
Tokai J Exp Clin Med; 1982 Mar; 7(2):145-58. PubMed ID: 7048633
[TBL] [Abstract][Full Text] [Related]
2. Occurrence and significance of IgG liver membrane autoantibodies (LMA) in chronic liver diseases of different aetiology.
Meliconi R; Stancari MV; Garagnani M; Baraldini M; Stefanini GF; Miglio F; Gasbarrini G
Clin Exp Immunol; 1983 Mar; 51(3):565-71. PubMed ID: 6342885
[TBL] [Abstract][Full Text] [Related]
3. LM-Ag and LSP--two different target antigens involved in the immunopathogenesis of chronic active hepatitis?
Meyer zum Büschenfelde KH; Manns M; Hütteroth TH; Hopf U; Arnold W
Clin Exp Immunol; 1979 Aug; 37(2):205-12. PubMed ID: 498582
[TBL] [Abstract][Full Text] [Related]
4. Occurrence and significance of antibody to liver-specific membrane lipoprotein by double-antibody immunoprecipitation method in sera of patients with acute and chronic liver diseases.
Kakumu S; Arakawa Y; Goji H; Kashio T; Yata K
Gastroenterology; 1979 Apr; 76(4):665-72. PubMed ID: 105959
[TBL] [Abstract][Full Text] [Related]
5. Antibodies against human liver-specific protein (LSP) in acute and chronic viral hepatitis types A, B and non-A, non-B.
Meliconi R; Baraldini M; Stefanini GF; Facchini A; Miglio F; Bortolotti F; Alberti A; Realdi G; Amoroso P
Clin Exp Immunol; 1981 Nov; 46(2):382-90. PubMed ID: 6802539
[TBL] [Abstract][Full Text] [Related]
6. Incidence of antibodies against rabbit liver specific lipoprotein (RLSP) in chronic active hepatitis.
Ortona L; Laghi V; Tamburrini E; Troncone L; Bonifazi N; Nervo P; Cauda R
Clin Exp Immunol; 1983 May; 52(2):437-40. PubMed ID: 6861379
[TBL] [Abstract][Full Text] [Related]
7. Species cross-reactivity of anti-LSP antibodies in acute viral hepatitis.
Perperas A; McFarlane BM; McSorley CG; McFarlane IG; Williams R
J Clin Lab Immunol; 1986 Jan; 19(1):25-30. PubMed ID: 2422379
[TBL] [Abstract][Full Text] [Related]
8. Autoantibodies against liver-specific membrane lipoprotein in acute and chronic liver diseases: studies on organ-, species-, and disease-specificity.
Manns M; Meyer zum Büschenfelde KH; Hess G
Gut; 1980 Nov; 21(11):955-61. PubMed ID: 7450561
[TBL] [Abstract][Full Text] [Related]
9. Liver autoreactivity in acute virus A, B and non-A, non-B hepatitis.
Vento S; McFarlane BM; McSorley CG; Ranieri S; Giuliani-Piccari G; Dal Monte PR; Verucchi G; Williams R; Chiodo F; McFarlane IG
J Clin Lab Immunol; 1988 Jan; 25(1):1-7. PubMed ID: 3133482
[TBL] [Abstract][Full Text] [Related]
10. Identification of the hepatic asialo-glycoprotein receptor (hepatic lectin) as a component of liver specific membrane lipoprotein (LSP).
McFarlane IG; McFarlane BM; Major GN; Tolley P; Williams R
Clin Exp Immunol; 1984 Feb; 55(2):347-54. PubMed ID: 6199139
[TBL] [Abstract][Full Text] [Related]
11. The relationship between liver-specific lipoprotein and the hepatocyte plasma membrane.
Bartholomaeus WN; Swanson NR; Reed WD; O'Donoghue HL; Foti D; Papadimitriou JM
Immunology; 1987 Mar; 60(3):321-9. PubMed ID: 3032778
[TBL] [Abstract][Full Text] [Related]
12. [Liver cell membrane autoantibody (LMA) in chronic liver disease].
Garagnani M; Meliconi R; Mazzoli M; Stancari V; Mariani AR; Morabito F; Miglio F; Facchini A
Boll Soc Ital Biol Sper; 1980 Aug; 56(15):1585-9. PubMed ID: 7459079
[TBL] [Abstract][Full Text] [Related]
13. Experimental liver membrane antibodies (LMA) and antibodies against "liver specific protein (LSP)"--a comparative in vitro study.
Stemerowicz R; Möller B; Jahn HU; Schwämmle K; Berg PA; Hopf U
J Clin Lab Immunol; 1990 May; 32(1):13-9. PubMed ID: 1967032
[TBL] [Abstract][Full Text] [Related]
14. Antibodies to liver cell membrane antigens in chronic active hepatitis (CAH). III. Partial characterization of the liver cell membrane antigens and comparison of reactivities in sera from patients with various liver diseases.
Frazer IH; Mackay IR
Clin Exp Immunol; 1984 Aug; 57(2):429-37. PubMed ID: 6432384
[TBL] [Abstract][Full Text] [Related]
15. Autoantibody against liver cell membrane and killer cell activity in chronic liver diseases.
Schnabel R; Dalmi L; Sipka S; Bokor M; Malatinszky G; Garam T
Acta Med Hung; 1991; 48(1-2):23-31. PubMed ID: 1813854
[TBL] [Abstract][Full Text] [Related]
16. [Immunopathology of chronic liver diseases].
Meyer zum Büschenfelde KH
Verh Dtsch Ges Pathol; 1995; 79():186-97. PubMed ID: 8600684
[TBL] [Abstract][Full Text] [Related]
17. Detection and characterization of liver membrane autoantibodies in chronic active hepatitis by a solid-phase radioimmunoassay.
Manns M; Meyer zum Büschenfelde KH; Hütteroth TH; Hess G
Clin Exp Immunol; 1980 Nov; 42(2):263-72. PubMed ID: 6781800
[TBL] [Abstract][Full Text] [Related]
18. Autoantibodies to liver-specific lipoprotein following hepatitis induced by mouse cytomegalovirus.
Bartholomaeus WN; Shellam GR; Allan JE; Reed WD; Joske RA
Clin Exp Immunol; 1983 Apr; 52(1):89-97. PubMed ID: 6305543
[TBL] [Abstract][Full Text] [Related]
19. [Immunopathological mechanisms responsible for hepatic lesions caused by B virus].
Vuitton D; Trepo C
Pathol Biol (Paris); 1984 Mar; 32(3):190-8. PubMed ID: 6201804
[TBL] [Abstract][Full Text] [Related]
20. [Possibilities for the use of immunofluorescence in clinical immunologic diagnosis].
Storch W
Acta Histochem Suppl; 1984; 30():89-92. PubMed ID: 6425963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
